Venus raised Indian voice against AMR and exhibited its innovative solution to combat AMR in the global event. Venus presented its innovation with Antibiotic Resistance Breaker in the event.

The World Antimicrobial Resistance Congress gathers key stakeholders from government, funding agencies, pharma, academia, hospitals, and payers to discuss this urgent need for new antibiotics and the current state of AMR. This 2-day conference presents solutions through keynotes, case study presentations, expert opinion, round table discussions and invites key influencers such as BARDA, NIH, FDA, grant agencies, pharma, hospitals, and academia, in the AMR discussion.

Venus Remedies Limited (VRL) a fully integrated, research-driven Indian Pharmaceutical company active in the development of effective treatments for life-threatening infectious diseases, represented at World AMR Congress 2017 and showcased its research on Antibiotic Resistance Breaker(ARB). Mrs. Manu Chaudhary, Ph.D., the company's Joint Managing Director cum Director research, delivered a keynote lecture at the 2017 World Antimicrobial Resistance Congress on September 14 in Washington, D.C. The keynote lecture titled "Are existing Antibiotics really worthless Demystifying Antibiotic Resistance Breakers" explored the possibilities to revive existing antibiotics by using ARB approach. She has also represented the screening of suitable ARB for Venus flagship product Elores.